Treatment with spironolactone for 24 weeks decreases the level of matrix metalloproteinases and improves cardiac function in patients with chronic heart failure of ischemic etiology
2009 ◽
Vol 25
(9)
◽
pp. 523-526
◽
2003 ◽
Vol 2
(1)
◽
pp. 96-97
Keyword(s):
2014 ◽
Vol 21
(7)
◽
pp. 712-729
◽
Keyword(s):
2011 ◽
Vol 13
(8)
◽
pp. 899-908
◽
2015 ◽
Vol 38
(5)
◽
pp. 409-415
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 21
(3)
◽
pp. 198-207
◽
2021 ◽
Keyword(s):